Clinical Cardiology

• 

  Publication Venue For

  • Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trial..  43:43-49. 2020
  • Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry..  43:24-32. 2020
  • Predictors of cardiorespiratory fitness improvement in phase II cardiac rehabilitation.  41:1563-1569. 2018
  • Atrial fibrillation in an African-American cohort: The Jackson Heart Study..  41:1049-1054. 2018
  • Race and Sex Differences in Management and Outcomes of Patients After ST-Elevation and Non-ST-Elevation Myocardial Infarct: Results From the NCDR..  39:585-595. 2016
  • Quality of care for patients with acute coronary syndromes as a function of hospital revascularization capability: Insights from get with the guidelines-CAD 2014
  • Impact of anemia on physical function and survival among patients with coronary artery disease..  31:546-550. 2008
  • Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes..  31:I2-I9. 2008
  • Antiplatelet therapy and platelet function testing. Introduction..  31:I1. 2008
  • Assessing the current role of platelet function testing..  31:I10-I16. 2008
  • Clinical considerations with the use of antiplatelet therapy in patients undergoing percutaneous coronary intervention..  31:I28-I35. 2008
  • Investigating the mechanisms of hyporesponse to antiplatelet approaches..  31:I21-I27. 2008
  • Prognostic value of troponins in patients with non-ST-segment elevation acute coronary syndromes and chronic kidney disease..  31:125-129. 2008
  • The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention..  31:I17-I20. 2008
  • The challenge of defining bleeding among patients with acute coronary syndromes..  30:II16-II23. 2007
  • The cardiovascular patient's perceptions of complementary and alternative medicine..  29:161-164. 2006
  • The significance of elevated troponin T in patients with nondialysis-dependent renal insufficiency: a validation with coronary angiography..  28:333-336. 2005
  • Vascular age: integrating carotid intima-media thickness measurements with global coronary risk assessment..  27:388-392. 2004
  • Recent update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: role of antiplatelet therapy..  27:119-120. 2004
  • Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study..  27:40-46. 2004
  • Conclusion.  25:33. 2002
  • Introduction: Redefining acute coronary syndrome care in the era of aggressive revascularization.  25:1. 2002
  • Matching resources to treatment decisions for patients with acute coronary syndromes..  25:I2-I8. 2002
  • Images in cardiology: Loeffler's endocarditis resulting from acute lymphoblastic leukemia..  25:345. 2002
  • A case of severe ischemia-induced QT prolongation..  24:750. 2001
  • A dietary approach to prevent hypertension: A review of the dietary approaches to stop hypertension (DASH) study.  22. 1999
  • A dietary approach to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) Study..  22:III6-II10. 1999
  • Enhanced external counterpulsation in the management of patients with cardiovascular disease..  22:173-178. 1999
  • Management strategies for a better outcome in unstable coronary artery disease.  21:314-322. 1998
  • Clinical outcomes according to time to treatment..  20:III11-III15. 1997
  • The need for wider utilization of thrombolytic therapy..  20:III26-III31. 1997
  • Angiotensin-II-receptors: new targets for antihypertensive therapy..  20:3-6. 1997
  • Dynamics of coronary thrombolysis and reocclusion.  20:III2-III5. 1997
  • Prehospital strategies to expedite myocardial salvage.  20:III16-III20. 1997
  • Reducing door-to-needle time: Treatment delay versus presentation delay.  20:III21-III25. 1997
  • Accelerated TPA for treatment of prosthetic valve thrombosis..  19:665-668. 1996
  • Transesophageal echocardiography in diagnosing cardioembolic stroke..  18:705-708. 1995
  • The role of prolonged thrombolytic infusions and transesophageal echocardiography in thrombosed prosthetic heart valves: case report and review of the literature..  18:679-684. 1995
  • The influence of angiographically demonstrated coronary collaterals on the results of stress echocardiography..  18:205-208. 1995
  • Local contractile and growth modulators in the myocardium..  16:II5-II9. 1993
  • Balloon dilatation of inferior vena cava obstruction in Budd-Chiari syndrome..  16:360-361. 1993
  • Authors' reply.  16:A22-A22. 1993
  • Panel discussion: Question and answer session.  16:30-31. 1993
  • Thrombolytic therapy for myocardial infarction: a perspective of clinical trialists. The GUSTO Investigators..  15:143-144. 1992
  • Safety and efficacy of sonicated albumin microspheres in perfusion and vein graft patency assessments..  14:V29-V32. 1991
  • Mitral annular calcification and coarctation of aorta..  11:578-580. 1988
  • Clinical assessment of beta blockade..  11:311-316. 1988
  • Position as a variable for cardiovascular responses during exercise..  10:137-142. 1987
  • Acute thrombosis of a composite ascending aortic conduit containing a Bjork-Shiley valve during pregnancy: successful emergency cesarean section and operative repair..  9:299-301. 1986
  • Prevalence of mitral valve prolapse in presumably healthy korean adults.  8:356-358. 1985
  • Correlation between calcific aortic stenosis diagnosed by two-dimensional echocardiography and cardiac catheterization..  7:280-282. 1984
  • Serial ambulatory monitoring in patients with unstable angina pectoris.  6:435-439. 1983
  • SAFETY AND EFFICACY OF SONICATED ALBUMIN MICROSPHERES IN PERFUSION AND VEIN GRAFT PATENCY ASSESSMENTS 1991